In the TARGET‐osteosarcoma dataset, we noticed that patients with higher IGHA1_B gene signature score were associated with better EFS and OS, suggesting tumour suppressive roles of IGHA1_B cells in osteosarcoma patients. This evidence concerns the gene IGHA1 and osteosarcoma.